Cannabis

After quarterly results fell short of his expectations, Beacon Securities analyst Russell Stanley has cut his price target on Vext Science (Vext Stock Quote, Chart, News, Analysts, Financials CSE:VEXT) in half. On November 28, Vext reported its Q3, 2023 results. The company posted Adjusted EBITDA of $1.08-million on revenue of $8.10-million, a topline that was […]

Following the company’s third quarter results, Haywood Capital Markets analyst Neal Gilmer has maintained his “Buy” rating on Cresco Labs (Cresco Labs Stock Quote, Chart, News, Analysts, Financials CSE:CL). On November 15, Cresco reported its Q3, 2023 results. The company posted Adjusted EBITDA of (US) $49-million on revenue of $191-million “Our third quarter results demonstrate […]